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Parvovirus B 19 infection in immunodeﬁcient patient
A.V. Lombar ∗, M. Segovia, C.M. Carranza, M.L. Chessari,
A.I. Sanchez, A.M. Assetta
Hospital General de Agudos José María Penna, Buenos Aires,
Buenos Aires, Argentina
Background: The parvovirus B 19 belongs to the Ery-
throvirus genus of the Parvoviridae Family. It was discovered
in 1974 by Yvonne Cossart in an assay for hepatitis B. The
Infection with Parvovirus B 19 is global. The normal mode of
transmission is by droplet infection or from person to person
through direct contact with respiratory secretions. A high
prevalence of Ig G antibodies to B 19 parvovirus was found
in the 75% of adult patients. Parvovirus B 19 has a speciﬁc
tropism for erythroid progenitor cells. In HIV patients there
may be persistent anemia with a pure red cell aplasia.
Methods: A 36 year old patient with a medical history of
smoking, drinking and addiction to inhalant drugs arrived at
the hospitalˇıs emergency department with a severe anemic
syndrome which had been evolving during three months. In
addition, a week prior to the patientˇıs arrival, he had suf-
fered from a syncoptic episode. On examination, the patient
was feverish, tachycardiac, normotensive, with no ortho-
statism, and dyspneic. The mucous and skin were pale. He
presented a 3/6 heart murmurs without irradiation
Results: Serologic tests for the human immunodeﬁciency
virus were positive CD 4 count of 186/ mm3. The patient
had a hematocrit of 6% and the hemogoblin level was 1,
06 g per deciliter. The level of of lactate dehydrogenase was
694. The mean corpuscularlar volume was 76, 47 um3 with
a mean corpuscular hemoglobin concentration of 29 g per
deciliter. The levels of blood glucose, electrolytes, calcium,
urea nitrogen, creatinine were normal. No reticulocytes
were found on several examinations. Examination of the
bone marrow biopsy showed pure red cell aplasia, Myeloid
elements showed complete maturation. A direct Coombs
test was negative. Anti parvovirus b 19M antibodies were
positive. The patient received speciﬁc treatment with intra-
venous human immunoglobulin 400mg/kg/ day over 5 days.
He showed improvement after immunoglobulin treatment.
The patient was discharged from the hospital with a hemat-
ocrit of 22%. Finally, he followed up medical examination in
an outpatient clinic.
Conclusion: Although parvovirus B 19 produces generally
banal infections in immunocompetent patients, immunode-
pressed patients may develop acute or chronic anemia due
to the lack of protective antibodies, along with hiccup or
chronic bone marrow aplasia.
doi:10.1016/j.ijid.2010.02.520
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Background: Human immunodeﬁciency virus (HIV) and
epatitis B virus (HBV) infection share common routes
f transmission and hence co-infection is common. Co-
nfection with HBV/HIV is associated with higher levels of
BV DNA, lower rates of spontaneous HBV eantigen sero-
onversion, more severe liver disease and increased rates
f liver-related mortality.
Chronic viral hepatitis has become an important cause of
orbidity and mortality in HIV coinfected patients. Start-
ng treatment appropriately, monitoring both HIV and HBV
esponse to treatment appropriately and surveillance for
iver disease progression is imperative. Current guidelines
ecommend 6 monthly alpha fetoprotein (AFP) and liver
ltrasound scans for hepatocellular carcinoma (HCC) surveil-
ance.
In 2009 an audit of HBV/HIV co-infected patients at our
ospital revealed that while HIV disease was being moni-
ored as per guidelines, markers for HBV replication and
eroconversion were measured on a variable basis. We found
uboptimal rates of monitoring for the development of HCC
sing either AFP or liver ultrasound. Finally, liver biopsies
ere infrequently requested in those who meet the criteria.
Methods: As a result of the above ﬁndings a number of
nterventions were made: Generation of a frequent speciﬁc
linic for HIV/HBV co-infected patients with multidisci-
linary team input.
Establishment of a regular teaching program with regards
o current practice guidelines for managing and monitoring
atients co-infected with HIV/HBV.
Collaboration with the Radiology Department to cre-
te a more efﬁcient and effective method of surveillance
adiology for these patients including automatic recall for
urveillance scans.
Results: Since establishment of the co-infection clinic
BV DNA continues to be monitored appropriately. More
atients had AFP levels checked on a 6 monthly basis (73%
s 20%). A greater proportion of patients (89% vs 45%) were
ooked for surveillance ultrasound.
Conclusion: Cohorting of HIV/HBV co-infected patients
esults in improved adherence to guidelines for HBV surveil-
ance and will facilitate future HBV studies including HBV
urface antigen quantiﬁcation, delta virus surveillance and
epatic elastography.
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